Clinical trial
Evaluation, Treatment, and Training for Patients With Blood Disorders
NCT00001397 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00001397 |
|---|---|
| Title | Evaluation, Treatment, and Training for Patients With Blood Disorders |
| Official title | Evaluation, Treatment and Training Protocol for Patients With Bone Marrow Failure States, Isolated or Multilineage Cytopenias, Metastatic Solid Tumors, or Hematologic Malignancies |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Hematologic Diseases |
| Enrollment | 1,452 |
| Start date | Nov 8, 1993 |
| Primary completion | Oct 5, 2020 |
| Completion | Oct 5, 2020 |
| First posted | Nov 4, 1999 |
| Last update posted | Oct 8, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: